Stockscreener 앱 받기
5.01
0.20%
-0.010
시간 외 거래:
5.01
전일 마감가:
$5.02
열려 있는:
$5.01
하루 거래량:
150.01K
Relative Volume:
0.58
시가총액:
$272.59M
수익:
$79.55M
순이익/손실:
$-37.25M
주가수익비율:
-7.1024
EPS:
-0.7054
순현금흐름:
$-25.40M
1주 성능:
+3.94%
1개월 성능:
+0.60%
6개월 성능:
-38.53%
1년 성능:
+24.32%
1일 변동 폭
$4.92
$5.2188
1주일 범위
$4.67
$5.30
52주 변동 폭
$3.11
$9.2362
Sight Sciences Inc Stock (SGHT) Company Profile
명칭
Sight Sciences Inc
전화
(415) 889-0550
주소
4040 CAMPBELL AVE,, MENLO PARK
Compare SGHT vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SGHT
Sight Sciences Inc
|
5.01 | 273.14M | 79.55M | -37.25M | -25.40M | -0.7054 |
ABT
Abbott Laboratories
|
88.50 | 154.45B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
301.14 | 118.05B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
78.14 | 103.20B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.95 | 69.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.68 | 49.68B | 6.30B | 1.07B | 1.09B | 1.8406 |
Sight Sciences Inc Stock (SGHT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-05 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2025-08-08 | 업그레이드 | Lake Street | Hold → Buy |
| 2024-12-06 | 개시 | UBS | Buy |
| 2024-11-04 | 다운그레이드 | Lake Street | Buy → Hold |
| 2024-08-21 | 개시 | Lake Street | Buy |
| 2023-09-12 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2023-09-12 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2023-09-12 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2023-08-24 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2023-07-10 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2023-01-06 | 업그레이드 | Stifel | Hold → Buy |
| 2022-10-04 | 개시 | Needham | Hold |
| 2022-07-26 | 개시 | Stifel | Hold |
| 2022-02-03 | 개시 | William Blair | Outperform |
| 2022-01-07 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
모두보기
Sight Sciences Inc 주식(SGHT)의 최신 뉴스
Sight Sciences director Encrantz buys $68,793 in company stock By Investing.com - Investing.com Nigeria
Sight Sciences director Encrantz buys $68,793 in company stock - Investing.com UK
Sight Sciences (SGHT) director boosts direct stake with 14,100-share buy - Stock Titan
Sight Sciences | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo
Discover 3 Promising Penny Stocks With Market Caps Over $20M - simplywall.st
Number of shareholders of Sight Sciences, Inc. – NASDAQ:SGHT - TradingView
Sight Sciences Shareholders Reelect Directors, Ratify Auditor - The Globe and Mail
Sight Sciences (SGHT) Dips 3.26% as Medical Device Stock Tests Key SupportLast Point Resistance - newsline.com
Sight Sciences (SGHT) grants RSU award to board director - Stock Titan
Sight Sciences (SGHT) director awarded 28,261 RSUs worth about $130,000 - Stock Titan
Sight Sciences (SGHT) grants $130K in RSUs to board director - Stock Titan
Sight Sciences (SGHT) director Donald Zurbay awarded 28,261 RSUs valued at about $130,000 - Stock Titan
Sight Sciences (NASDAQ: SGHT) director receives 28,261 RSUs grant - Stock Titan
Sight Sciences (NASDAQ: SGHT) reports 2026 shareholder meeting voting results - Stock Titan
Sight Sciences (SGHT) Q1 earnings: How key metrics compare to Wall Street estimates - MSN
Sight Sciences, Inc. (SGHT) Reports Q1 Loss, Beats Revenue Estimates - Eastern Progress
Sight Sciences Inc. (SGHT) Nears Key Support After 3.95% DeclineTrading Ideas - The Legal Advocate
Sight Sciences Inc stock (US8177721062): Nasdaq-listed eye-care player sees muted trading ahead of Q - AD HOC NEWS
Sight Sciences Inc. (SGHT) Nears Support as Shares Edge LowerFibonacci Retracement - newsline.com
SGHT Maintained by Citigroup -- Price Target Raised to $5.15 - GuruFocus
Sight Sciences Drops in Pre-Market Trade as Investors Watch SGHT Growth - Bez Kabli
Sight Sciences | 4: Statement of changes in beneficial ownership of securities-Officer Bauerlein Alison - Moomoo
Sight Sciences wins $34M patent ruling against Alcon - MSN
Sight Sciences Inc. (SGHT) Q1 2026 Earnings: EPS Misses Estimates as Operating Losses WidenEarnings Growth Analysis - Newser
Sight Sciences Inc. (SGHT) Q1 2026 Earnings: Wider-Than-Expected Loss Drags Stock Down Over 2%Tax Rate Impact - Newser
Sight Sciences stock (US8177721062): eye-care specialist in focus after latest business update - AD HOC NEWS
Sight Sciences (SGHT) Q1 2026 Results Disappoint — Multiple Headwinds CitedSocial Buzz Stocks - Newser
Sight Sciences (SGHT) Fell -0.64% — Is a Recovery Ahead? 2026-05-20Sector Neutral Pair - Newser
Sight Sciences (SGHT) COO sells 12,728 shares to cover RSU tax obligations - Stock Titan
Sight Sciences stock (US8177721062): eye-care specialist in focus after recent earnings and FDA upda - AD HOC NEWS
Sight Sciences appoints Ali Bauerlein as COO and Jim Rodberg as CFO - MSN
Sight Sciences signals $83M-$89M 2026 revenue outlook while targeting $6M-$8M dry eye sales - MSN
sight sciences, inc. Earnings dates - RTTNews
Affiliate plans sale of 12,728 SGHT shares (NASDAQ: SGHT) via Fidelity - Stock Titan
Sight Sciences, Inc. (NASDAQ:SGHT) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
TradingKey - TradingKey
Sight Sciences (SGHT) Climbs +2.86% — Resistance at $5.29 in Focus 2026-05-14Price Target - newsline.com
SGHT (Sight Sciences) posts wider-than-expected loss as earnings miss forecasts by 42%, shares dip.Wall Street Picks - Newser
Sight Sciences (SGHT) Q1 Loss Of US$0.24 EPS Tests Margin Improvement Narrative - Sahm
SGHT (Sight Sciences) beats Q1 earnings estimates by 5.1% as shares climb 1.70% on optimism.Trader Community Insights - newser.com
Insiders At Sight Sciences Sold US$1.8m In Stock, Alluding To Potential Weakness - Moomoo
Sight Sciences(SGHT) Stock Options Chain | Quotes & News - Moomoo
Stifel Nicolaus Sticks to Their Buy Rating for Sight Sciences (SGHT) - The Globe and Mail
Sight Sciences Financial Results for Q1 2026 Show Growth - VisionMonday.com
Sight Sciences Earnings Call Signals Disciplined Growth - TipRanks
Lake Street Initiates Sight Sciences(SGHT.US) With Buy Rating, Announces Target Price $12 - Moomoo
Sight Sciences, Inc. (NASDAQ:SGHT) Q1 2026 Earnings Call Transcript - Insider Monkey
Needham Maintains Sight Sciences(SGHT.US) With Hold Rating - Moomoo
Piper Sandler Maintains Sight Sciences(SGHT.US) With Buy Rating, Maintains Target Price $9 - Moomoo
Sight Sciences (SGHT) Q1 2026 Earnings Transcript - AOL.com
Sight Sciences Q1 Earnings Call Highlights - Yahoo Finance
Sight Sciences Inc (SGHT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Sight Sciences Inc 주식 (SGHT) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Bauerlein Alison | Chief Operating Officer |
May 18 '26 |
Sale |
5.12 |
12,728 |
65,167 |
688,893 |
2.43%
자본화:
|
볼륨(24시간):